vs
Side-by-side financial comparison of CorMedix Inc. (CRMD) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.
CorMedix Inc. is the larger business by last-quarter revenue ($128.6M vs $66.7M, roughly 1.9× RMR GROUP INC.).
CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.
RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.
CRMD vs RMR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $128.6M | $66.7M |
| Net Profit | — | $12.2M |
| Gross Margin | 83.4% | — |
| Operating Margin | 46.0% | 48.1% |
| Net Margin | — | 18.3% |
| Revenue YoY | — | 40.8% |
| Net Profit YoY | — | 91.1% |
| EPS (diluted) | $0.20 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $128.6M | $66.7M | ||
| Q3 25 | $104.3M | — | ||
| Q2 25 | $39.7M | — | ||
| Q1 25 | $39.1M | — |
| Q4 25 | — | $12.2M | ||
| Q3 25 | $108.6M | — | ||
| Q2 25 | $19.8M | — | ||
| Q1 25 | $20.6M | — |
| Q4 25 | 83.4% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 95.3% | — | ||
| Q1 25 | 95.9% | — |
| Q4 25 | 46.0% | 48.1% | ||
| Q3 25 | 49.2% | — | ||
| Q2 25 | 49.2% | — | ||
| Q1 25 | 51.5% | — |
| Q4 25 | — | 18.3% | ||
| Q3 25 | 104.1% | — | ||
| Q2 25 | 49.9% | — | ||
| Q1 25 | 52.8% | — |
| Q4 25 | $0.20 | $0.71 | ||
| Q3 25 | $1.26 | — | ||
| Q2 25 | $0.28 | — | ||
| Q1 25 | $0.30 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $148.5M | $49.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $405.3M | $232.7M |
| Total Assets | $826.1M | $687.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $148.5M | $49.3M | ||
| Q3 25 | $55.7M | — | ||
| Q2 25 | $190.7M | — | ||
| Q1 25 | $77.5M | — |
| Q4 25 | $405.3M | $232.7M | ||
| Q3 25 | $374.1M | — | ||
| Q2 25 | $220.6M | — | ||
| Q1 25 | $114.9M | — |
| Q4 25 | $826.1M | $687.1M | ||
| Q3 25 | $750.9M | — | ||
| Q2 25 | $252.6M | — | ||
| Q1 25 | $149.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $94.5M | $10.7M |
| Free Cash FlowOCF − Capex | $92.7M | — |
| FCF MarginFCF / Revenue | 72.1% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | — | 0.88× |
| TTM Free Cash FlowTrailing 4 quarters | $172.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $94.5M | $10.7M | ||
| Q3 25 | $30.9M | — | ||
| Q2 25 | $30.0M | — | ||
| Q1 25 | $19.7M | — |
| Q4 25 | $92.7M | — | ||
| Q3 25 | $30.4M | — | ||
| Q2 25 | $30.0M | — | ||
| Q1 25 | $19.7M | — |
| Q4 25 | 72.1% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 75.4% | — | ||
| Q1 25 | 50.5% | — |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — |
| Q4 25 | — | 0.88× | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
